tiprankstipranks
Kyntra Bio (KYNB)
NASDAQ:KYNB
US Market
KYNB
Kyntra Bio
RESEARCH TOOLSreports
Want to see KYNB full AI Analyst Report?

Kyntra Bio (KYNB) Stock News & Sentiment

1,063 Followers
Kyntra Bio Warned of Nasdaq Non‑Compliance, Faces Delisting Risk Without Remediation Plan by May 18, 2026
Premium
Company Announcements
Kyntra Bio Warned of Nasdaq Non‑Compliance, Faces Delisting Risk Without Remediation Plan by May 18, 2026
9d ago
KYNB
FibroGen Earnings Call Highlights Clinical Momentum, Runway
Premium
Company Announcements
FibroGen Earnings Call Highlights Clinical Momentum, Runway
10d ago
KYNB
Kyntra: Advancing Oncology and LR-MDS Programs with Strong Cash Position; Buy Rating and $43 Price Target Reiterated
Premium
Ratings
Kyntra: Advancing Oncology and LR-MDS Programs with Strong Cash Position; Buy Rating and $43 Price Target Reiterated
10d ago
KYNB
FGEN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
FGEN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
14d ago
KYNB
Kyntra Bio Faces Nasdaq Compliance Challenge After Revenue Shift
Premium
Company Announcements
Kyntra Bio Faces Nasdaq Compliance Challenge After Revenue Shift
1M ago
8K
KYNB
FibroGen Earnings Call: Cash-Rich, Data-Heavy, Unproven
Premium
Company Announcements
FibroGen Earnings Call: Cash-Rich, Data-Heavy, Unproven
2M ago
KYNB
Advancing Pipeline and 2026 Clinical Catalysts Underpin Buy Rating on Kyntra Bio
Premium
Ratings
Advancing Pipeline and 2026 Clinical Catalysts Underpin Buy Rating on Kyntra Bio
2M ago
KYNB
More KYNB News >

KYNB News on the Web

Kyntra Bio Rocked by CEO’s Sudden Insider Stock Sale
TipRanks News
Bearish
Kyntra Bio Warned of Nasdaq Non‑Compliance, Faces Delisting Risk Without Remediation Plan by May 18, 2026
TipRanks News
Bearish
FibroGen Earnings Call Highlights Clinical Momentum, Runway
TipRanks News
Neutral
Kyntra: Advancing Oncology and LR-MDS Programs with Strong Cash Position; Buy Rating and $43 Price Target Reiterated
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: CVRx (CVRX) and Kyntra Bio (KYNB)
TipRanks News
Neutral
Kyntra Bio Inc (KYNB) Q1 2026 Earnings Call Highlights: Revenue Growth and Strategic Advances ...
GuruFocus News
Bullish
Is Kyntra Bio (KYNB) 31.3% Overvalued After Q1 2026 Earnings Beat? EPS -$3.76 (beat vs -$4. ...
GuruFocus News
Neutral
FGEN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
TipRanks News
Neutral

News Score - Last 7 Days

Very Negative
KYNB
Sector Average
Media Buzz
This Week1 articles
Weekly Average1.75 articles
News Sentiment
This Week0%
Sector Average79%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is KYNB’s Media Buzz Sentiment?
1 articles about KYNB were published this week. In an average week, 1.75 articles are published.
    What is KYNB’s weekly average amount of articles?
    In an average week, 1.75 articles about KYNB are published.
      What is KYNB’s News Sentiment?
      Currently, no data Available
      Healthcare Stocks that are Trending in the News
      GOSSGossamer Bio
      RLAYRelay Therapeutics
      ROIVRoivant Sciences
      ILAIsland Pharmaceuticals Ltd
      JUNSJupiter Neurosciences, Inc.
      Showing the stocks with the most bullish news sentiment over the past week